Development of Beta-Amyloid-Specific CAR-Tregs for the Treatment of Alzheimer's Disease.

Valerie Saetzler Tobias RietAndrea SchienkePierre HenschelKiara FreitagAlexander HaakeFrank L Heppner Laura Elisa Buitrago-MolinaFatih NoyanElmar JaeckelMatthias Hardtke-Wolenski

Published in: Cells (2023)

This study highlights the potential of CAR technology to generate antigen-specific Tregs and presents novel approaches for developing functional CARs.

Keyphrases

human health
combination therapy
risk assessment
climate change
mild cognitive impairment
replacement therapy